4
Changes in Ownership
PTC THERAPEUTICS, INC. Filed Acc 0001415889-23-008390
CHIEF BUSINESS OFFICER sold 8,836 shares at an average $58.52 ($517,089)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pauwels Eric CHIEF BUSINESS OFFICER | 2023-05-17 | Sale 10b5-1 | −800 | $58.52 | $46,814 | 64,005 | D: show line 1 in the form |
| Pauwels Eric CHIEF BUSINESS OFFICER | 2023-05-17 | Sale 10b5-1 | −7,248 | $58.50 | $424,008 | 56,757 | D: show line 2 in the form |
| Pauwels Eric CHIEF BUSINESS OFFICER | 2023-05-18 | Sale 10b5-1 | −788 | $58.71 | $46,267 | 55,969 | D: show line 3 in the form |
| Open-market sales · 8,836 sh · avg $58.52 · $517,089 | |||||||
Loading xslF345X04/form4-05192023_080525.xml…